[go: up one dir, main page]

ES2031813T3 - Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona. - Google Patents

Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona.

Info

Publication number
ES2031813T3
ES2031813T3 ES198686114241T ES86114241T ES2031813T3 ES 2031813 T3 ES2031813 T3 ES 2031813T3 ES 198686114241 T ES198686114241 T ES 198686114241T ES 86114241 T ES86114241 T ES 86114241T ES 2031813 T3 ES2031813 T3 ES 2031813T3
Authority
ES
Spain
Prior art keywords
derivatives
procedure
cuanilo
alquilamino
alcoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686114241T
Other languages
English (en)
Inventor
Jurgen Dr. Engel
Gerhard Dr. Scheffler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Application granted granted Critical
Publication of ES2031813T3 publication Critical patent/ES2031813T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DERIVADOS DE 4-BENCIL-1-(2H)-HALAZINONA DE EFECTO ANTIALERGICO DE LA FORMULA FIGXX DONDE R1 ES FLUOR, CLORO, BROMO, TRIFLUOROMETILO, C1-C6ALQUILO, HIDROXI, C1-C6-ALCOXI, C2-C6-ALCANOILOXI, AMINO, C1-C6-ALQUILAMINO, DI-C1-C6-ALQUILAMINO, C2-C6-ALCANOILAMINO, C2-C6-ALCANOIL-C1-C6-ALQUILAMINO O UN GRUPO NITRO R2 ES HIDROGENO O UNO DE LOS CITADOS PARA R1 DE DONDE R1 Y R2 PUEDEN SER IGUALES O DIFERENTES, Y SIGNIFICAN HIDROGENO, HALOGENO, C1-C6-ALQUILO, HIDROXI, C1-C6-ALCOXI, BENZOILOXI O C2-C2-ALCANOILOXI Y A ES UN RESTO AZACICLOALCANILO, CUYO NITROGENO AZA CONTIENE UN GRUPO C1-C6 ALQUILO, QUE SE SUSTITUYE POR DIFERENTES RESTOS, Y PROCEDIMIENTO PARA SU OBTENCION.
ES198686114241T 1985-11-11 1986-10-15 Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona. Expired - Lifetime ES2031813T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3539873 1985-11-11

Publications (1)

Publication Number Publication Date
ES2031813T3 true ES2031813T3 (es) 1993-01-01

Family

ID=6285623

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686114241T Expired - Lifetime ES2031813T3 (es) 1985-11-11 1986-10-15 Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona.

Country Status (20)

Country Link
US (1) US4841047A (es)
EP (1) EP0222191B1 (es)
JP (1) JPH0780871B2 (es)
CN (1) CN86107627A (es)
AT (1) ATE60598T1 (es)
AU (1) AU593593B2 (es)
CA (1) CA1295613C (es)
DD (1) DD263058A5 (es)
DE (1) DE3677322D1 (es)
DK (1) DK172076B1 (es)
ES (1) ES2031813T3 (es)
FI (1) FI88504C (es)
GR (1) GR3001412T3 (es)
HU (1) HU196793B (es)
IE (1) IE59056B1 (es)
IL (1) IL80560A0 (es)
NO (1) NO864474L (es)
PT (1) PT83713B (es)
SU (1) SU1454251A3 (es)
ZA (1) ZA868531B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88984B (pt) * 1987-11-13 1993-01-29 Asta Medica Ag Processo para a preparação de embonato de azelastina e de composições earmacâutxcas que 0 contêm como ingrediente activo
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DK0396069T3 (da) * 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
EP0561166A1 (de) * 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
DE60335359D1 (de) * 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
LT2377557T (lt) 2004-11-24 2017-02-10 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) * 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
JP4489143B2 (ja) * 2006-04-20 2010-06-23 グラクソ グループ リミテッド ヒスタミンh1及びh3アンタゴニストとしての2−置換4−ベンジルフタラジノン誘導体
US20090181951A1 (en) * 2006-06-15 2009-07-16 Kudos Pharmaceuticals Limited Parp inhibitors
EP2041087A1 (en) * 2006-06-15 2009-04-01 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
WO2007144637A1 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited 2 -oxyheteroarylamide derivatives as parp inhibitors
UY30639A1 (es) * 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
TW200831493A (en) * 2006-12-20 2008-08-01 Glaxo Group Ltd Compounds
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
KR20100059950A (ko) 2007-09-14 2010-06-04 아스트라제네카 아베 프탈라지논 유도체
ATE525370T1 (de) * 2007-10-11 2011-10-15 Glaxo Group Ltd Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten
JP5593229B2 (ja) * 2007-10-17 2014-09-17 クドス ファーマシューティカルズ リミテッド 4−[3−(4−シクロプロパンカルボニル−ピペラジン−1−カルボニル)−4−フルオロ−ベンジル]−2h−フタラジン−1−オン
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
HUE030800T2 (en) * 2008-10-07 2017-05-29 Astrazeneca Uk Ltd Pharmaceutical Form No. 514
WO2011007145A1 (en) * 2009-07-15 2011-01-20 Astrazeneca Ab Phthalazinone compound as parp inhibitor
CN113956239A (zh) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 一种盐酸氮卓斯汀及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017411A (en) * 1962-01-16 New substituted phthalazones and proc-
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
ATE49205T1 (de) * 1984-09-14 1990-01-15 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
DE3530793A1 (de) * 1984-09-14 1986-03-27 Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld Substituierte benzylphthalazinon-derivate

Also Published As

Publication number Publication date
PT83713B (pt) 1989-06-30
FI88504C (fi) 1993-05-25
NO864474L (no) 1987-05-12
JPH0780871B2 (ja) 1995-08-30
IE59056B1 (en) 1993-12-15
AU593593B2 (en) 1990-02-15
PT83713A (de) 1986-12-01
IL80560A0 (en) 1987-02-27
DD263058A5 (de) 1988-12-21
CN86107627A (zh) 1987-07-15
DK536486A (da) 1987-05-12
DK172076B1 (da) 1997-10-13
IE862960L (en) 1987-05-11
EP0222191B1 (de) 1991-01-30
DK536486D0 (da) 1986-11-10
JPS62114987A (ja) 1987-05-26
DE3677322D1 (de) 1991-03-07
FI88504B (fi) 1993-02-15
NO864474D0 (no) 1986-11-10
ATE60598T1 (de) 1991-02-15
EP0222191A1 (de) 1987-05-20
GR3001412T3 (en) 1992-09-25
AU6498286A (en) 1987-05-14
SU1454251A3 (ru) 1989-01-23
HU196793B (en) 1989-01-30
CA1295613C (en) 1992-02-11
ZA868531B (en) 1987-07-29
US4841047A (en) 1989-06-20
FI864555A7 (fi) 1987-05-12
FI864555A0 (fi) 1986-11-10
HUT42084A (en) 1987-06-29

Similar Documents

Publication Publication Date Title
ES2031813T3 (es) Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona.
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
AR241247A1 (es) Procedimiento para la preparacion de nuevos derivados de imidazo ¡4,5-c¿ piridina.
ES2152317T3 (es) Derivados de arilideno y de heteroarilideno oxiindol utilizados como inhibidores de la tirosina quinasa.
ES2196554T3 (es) Derivados del 1,4-diazacicloheptano y su empleo en tintes para el cabello por oxidacion.
ES2165357T3 (es) Derivados de metileno-oxiindol y procedimiento de elaboracion.
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ES444935A1 (es) Procedimiento para preparar eteres benzoilurcido-difenili- cos.
ES2040715T3 (es) Derivados de pirimidina, su fabricacion y los medicamentos que los contienen.
ES8601992A1 (es) Procedimiento para preparar 2-fenil-imidazoles
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8103745A1 (es) Procedimiento para la preparacion de derivados de pirido (2,1-b) quinazolinona
ES450741A1 (es) Procedimiento para preparar derivados de vincamina.
ES8705453A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES8300104A1 (es) Un procedimiento para obtener derivados de benzopirano
DK150187D0 (da) Fremgangsmaade til fremstilling af hydroxyaminderivater
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
PE20030346A1 (es) Proceso para la produccion de quinazolinas
ES8106283A1 (es) Un procedimiento para la preparacion de precursores de alil sulfoxidos inhibidores de enzimas.
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
ES8802051A1 (es) Un metodo para preparar derivados de 9-bencilpurina
ES553826A0 (es) Procedimiento para preparar derivados de difluorociclopropano
GB982267A (en) New anthraquinone dyes
ES345741A1 (es) Procedimiento para la obtencion de colorantes monoazoicos.
GB969060A (en) Improvements relating to anthraquinone dyestuffs, their production and use